KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Debt to Equity (2016 - 2025)

Amgen has reported Debt to Equity over the past 17 years, most recently at $6.31 for Q4 2025.

  • Quarterly results put Debt to Equity at $6.31 for Q4 2025, down 38.33% from a year ago — trailing twelve months through Dec 2025 was $6.31 (down 38.33% YoY), and the annual figure for FY2025 was $6.31, down 38.33%.
  • Debt to Equity for Q4 2025 was $6.31 at Amgen, up from $5.67 in the prior quarter.
  • Over the last five years, Debt to Equity for AMGN hit a ceiling of $40.23 in Q1 2022 and a floor of $3.5 in Q1 2021.
  • Median Debt to Equity over the past 5 years was $9.16 (2023), compared with a mean of $10.14.
  • Biggest five-year swings in Debt to Equity: soared 1048.97% in 2022 and later plummeted 71.37% in 2023.
  • Amgen's Debt to Equity stood at $4.97 in 2021, then surged by 113.98% to $10.64 in 2022, then dropped by 2.54% to $10.37 in 2023, then decreased by 1.37% to $10.23 in 2024, then crashed by 38.33% to $6.31 in 2025.
  • The last three reported values for Debt to Equity were $6.31 (Q4 2025), $5.67 (Q3 2025), and $7.57 (Q2 2025) per Business Quant data.